Cover Image
市場調查報告書

Imipenem、Cilastatin sodium的中國市場分析

Investigation Report on China Imipenem and cilastatin sodium Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 333627
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Imipenem、Cilastatin sodium的中國市場分析 Investigation Report on China Imipenem and cilastatin sodium Market, 2010-2019
出版日期: 2015年06月25日 內容資訊: 英文 30 Pages
簡介

Imipenem、Cilastatin sodium,是因各種病因、細菌原因感染複數感染疾病時治療用 (在識別病原體之前) 處方。中國國內的銷售額,2005年達2億人民幣,2014年達5億9500萬人民幣,以25.4%年複合成長率(CAGR) 擴大。但今後隨著青黴烯抗生素的開發進行,預計市場競爭激烈。

本報告提供中國的Imipenem、Cilastatin sodium的市場相關分析、整體市場規模趨勢(過去5年份)和國內價格趨勢、各企業、各投藥形態的市場佔有率、主要製造商簡介、未來市場趨勢預測(今後5年份)等調查評估。

第1章 Imipenem、Cilastatin sodium的相關概念

  • 症狀
  • 全球市場的銷售情形

第2章 中國的Imipenem、Cilastatin sodium市場概況

  • 中國國內的Imipenem、Cilastatin sodium的專利申請、認證情形
  • 主要製造商
  • 市場規模

第3章 Imipenem、Cilastatin sodium銷售情形分析 (過去5年份)

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售量

第4章 中國的Imipenem、Cilastatin sodium市場:主要廠商的市場佔有率分析 (過去5年份)

  • 市場佔有率 (銷售額為基礎)
  • 市場佔有率 (銷售量為基礎)

第5章 中國的Imipenem、Cilastatin sodium市場:各劑型分析 (過去5年份)

  • 各劑型的市場佔有率 (銷售額為基礎)
  • 各劑型的市場佔有率 (銷售量為基礎)

第6章 Imipenem、Cilastatin sodium的醫院用標準價格

  • RANBAXY LABORATORIES LTD (印尼) (商標名:Bacqure)
  • Choongwae Pharma Corporation Korea (商標名:Prepenemtm)
  • China National Medicines Guorui Pharmaceutical Co., Ltd (商標名:Kaluoxin)
  • Yungjin Pharm. Co., Ltd (韓國)
  • Hisun Pfizer Pharmaceutical Co., Ltd
  • Shenzhen Haibin Pharmaceutical Co., Ltd (商標名:Beineng)
  • United Laboratories
  • Merck & Sharp Dohme (美國) (Trade Name: Tienam)

第7章 中國國內的Imipenem、Cilastatin sodium的主要製造商

  • Merck & Sharp Dohme (美國)
  • United Laboratories
  • Hisun Pfizer Pharmaceutical Co., Ltd
  • Shenzhen Haibin Pharmaceutical Co., Ltd
  • RANBAXY LABORATORIES LTD (印尼)

第8章 中國的Imipenem、Cilastatin sodium市場未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭環境預測

圖表一覽

目錄
Product Code: 1506232

Coming into being in the 1980s, penem is an unsatured beta-lactam featuring broad spectrum, strong effect and low resistance rate. Actually it is the most potent antibiotic with the broadest antibacterial spectrum hitherto. And Imipenem cilastatin is one of the commercially available penem class.

Developed by Merck & Sharp Dohme (US) in 1979, imipenem and cilastatin sodium is the most famous one in imipenem cilastatin class. Its sales value around the world was USD 610 million in 2011 and USD 520 million in 2012, down 25.4% year-on-year. And imipenem and cilastatin sodium is used for the treatment of mixed infection caused by a variety of pathogens and aerobic or anaerobic bacteria as well as the early treatment before pathogens are identified.

Imipenem and cilastatin sodium develops fast after entering China with annual sales value rising from less than CNY 200 million in 2005 to CNY 595 million in 2014 and CAGR during this period reaching 15.6%. Currently, imipenem and cilastatin sodium in the Chinese market mainly come from the following companies: Merck & Sharp Dohme (US), United Laboratories, RANBAXY LABORATORIES LTD(ID) and Shenzhen Haibin Pharmaceutical Co., Ltd, among which Merck & Sharp Dohme (US) has the largest market share of 90% for sales value in 2014.

As the development programs and manufacturers of penem antibiotics increase, the market competition will become more and more severe in future. The market size of imipenem and cilastatin sodium is expected to keep expanding in the next few years in China.

Readers can get at least the following information from this report:

  • market size of imipenem and cilastatin sodium in China
  • competitive landscape of imipenem and cilastatin sodium in Chinese market
  • price of imipenem and cilastatin sodium made by different enterprises in China
  • market outlook of imipenem and cilastatin sodium in China

The author suggests the following groups of people purchase this report:

  • manufacturers of anti-infective drugs
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Imipenem and cilastatin sodium

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Imipenem and cilastatin sodium in China

  • 2.1. Patent and Approval Status of Imipenem and cilastatin sodium in China
  • 2.2. Major Manufacturers

23. Market Size

3. Survey on Sales Status of Imipenem and cilastatin sodium in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Imipenem and cilastatin sodium in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Imipenem and cilastatin sodium in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Imipenem and cilastatin sodium in Chinese Hospitals in 2014

  • 6.1. RANBAXY LABORATORIES LTD(ID) (Trade Name: Bacqure)
  • 6.2. Choongwae Pharma Corporation Korea(Trade Name: Prepenemtm)
  • 6.3. China National Medicines Guorui Pharmaceutical Co., Ltd (Trade Name: Kaluoxin)
  • 6.4. Yungjin Pharm. Co., Ltd (KE)
  • 6.5. Hisun Pfizer Pharmaceutical Co., Ltd
  • 6.6. Shenzhen Haibin Pharmaceutical Co., Ltd (Trade Name: Beineng)
  • 6.7. United Laboratories
  • 6.8. Merck & Sharp Dohme (US) (Trade Name: Tienam)

7. Major Manufacturers of Imipenem and cilastatin sodium in Chinese Market, 2010-2014

  • 7.1. Merck & Sharp Dohme (US)
  • 7.2. United Laboratories
  • 7.3. Hisun Pfizer Pharmaceutical Co., Ltd
  • 7.4. Shenzhen Haibin Pharmaceutical Co., Ltd
  • 7.5. RANBAXY LABORATORIES LTD(ID)
  • 7.5. RANBAXY LABORATORIES LTD(ID)

8. Market Outlook of Imipenem and cilastatin sodium in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Approval Information of Imipenem and cilastatin sodium in China
  • Chart Sales Status of Imipenem and cilastatin sodium in China, 2010-2014
  • Chart Sales Value of Imipenem and cilastatin sodium in China, 2010-2014
  • Chart Sales Value of Imipenem and cilastatin sodium in Some Regions in China, 2010-2014
  • Chart Sales Volume of Imipenem and cilastatin sodium in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Imipenem and cilastatin sodium for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Imipenem and cilastatin sodium Made by Merck & Sharp Dohme (US) in China, 2010-2014
  • Chart Sales Value and Market Share of Imipenem and cilastatin sodium Made by Hisun Pfizer Pharmaceutical Co., Ltd in China, 2010-2014
  • Chart Sales Value and Market Share of Imipenem and cilastatin sodium Made by United Laboratories in China, 2010-2014
  • Chart Sales Value and Market Share of Imipenem and cilastatin sodium Made by RANBAXY(ID) in China, 2010-2014
  • Chart Price of Imipenem and cilastatin sodium Made by RANBAXY LABORATORIES LTD(ID) in Some Chinese Cities in 2014
  • Chart Price of Imipenem and cilastatin sodium Made by Choongwae Pharma Corporation Korea in Some Chinese Cities in 2014
  • Chart Price of Imipenem and cilastatin sodium Made by China National Medicines Guorui Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Imipenem and cilastatin sodium Made by Yungjin Pharm. Co., Ltd (KE) in Some Chinese Cities in 2014
  • Chart Price of Imipenem and cilastatin sodium Made by Hisun Pfizer Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Imipenem and cilastatin sodium Made by Shenzhen Haibin Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Imipenem and cilastatin sodium Made by United Laboratories in Some Chinese Cities in 2014
  • Chart Price of Imipenem and cilastatin sodium Made by Merck & Sharp Dohme (US) in Some Chinese Cities in 2014
Back to Top